SERA

Neutral

Whetstone/Atterbury amend 8.6% stake in Sera Prognostics (NASDAQ: SERA)

Whetstone Capital Advisors, LLC and David Atterbury have amended their stake in Sera Prognostics (NASDAQ: SERA), now reporting beneficial ownership of...

Stock Titan 21 hours ago 0

Neutral

Sera Prognostics (Nasdaq:SERA) - Stock Analysis

This Simply Wall St analysis provides a comprehensive overview of Sera Prognostics (SERA), a women's health company. It details SERA's market capitali...

Simply Wall Street 2 weeks ago 0